Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Navigation/Suche

Spiegelberg, J.
Renal cell carcinoma
MEMO-MAG EUR MED ONC. 2023; Doi: 10.1007/s12254-023-00918-w
Web of Science FullText FullText_MUG

Führende Autor*innen der Med Uni Graz: Spiegelberg Jasmin Alija
Altmetrics:
Dimensions Citations:
Plum Analytics:
Scite (citation analytics):
Abstract:: Kidney cancer accounts for 5% and 3% of all adult malignancies in men and women. Renal cell carcinoma (RCC) accounts for approximately 80% of all kidney cancer.This year's American Society of Clinical Oncology (ASCO) Annual Meeting was held from 2-6 June 2023, in Chicago, USA. Combination therapies for advanced RCC continue to be of interest at ASCO 2023, with the presentation of updated results from some ongoing studies. There were several studies presented at ASCO looking at treatments for non clear renal cell carcinoma. Immunotherapy- based therapy regimes are now the gold standard for rare histological subtypes of RCC.
Find related publications in this database (Keywords): IMDC risk groups; Combination therapies; Triplet therapy; Non-clear renal cell carcinoma; Metastasis